Skip to main content

Table 1 AACE lipid targets for patients with T2DM

From: Common medications used by patients with type 2 diabetes mellitus: what are their effects on the lipid profile?

Lipid High-risk patients (T2DM but no other major risk and/or age <40 years) Very-high-risk patients (T2DM plus ≥1 major ASCVD riska or ASCVDb)
LDL-C <100 mg/dL [<2.59 mmol/L] <70 mg/dL [<1.81 mmol/L]
Non-HDL-C <130 mg/dL [<3.37 mmol/L] <100 mg/dL [<2.59 mmol/L]
TGs <150 mg/dL [<1.69 mmol/L] <150 mg/dL [<1.69 mmol/L]
TC/HDL-C <3.5 <3.0
Apo B <90 mg/dL [<0.90 g/L] <80 mg/dL [<0.80 g/L]
LDL-P <1200 nmol/L <1000 nmol/L
  1. AACE American Association of Clinical Endocrinologists, apo B apolipoprotein B, ASCVD atherosclerotic cardiovascular disease, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, LDL-P low-density lipoprotein particle, T2DM type 2 diabetes mellitus, TC total cholesterol, TG triglyceride
  2. aHypertension, family history of ASCVD, low HDL-C, smoking
  3. bEven more intensive therapy might be warranted